Literature DB >> 19526315

Cancer cell lines release glutamate into the extracellular environment.

Eric P Seidlitz1, Mohit K Sharma, Zeina Saikali, Michelle Ghert, Gurmit Singh.   

Abstract

Bone is one of the most frequent sites for metastasis of breast and prostate cancers. Bone metastases are associated with pathologic changes in bone turnover and severe pain. The mechanisms that trigger these effects are not well understood, but it is postulated that tumour cells release factors which interfere with signalling processes critical to bone homeostasis. We have identified that several cancer cell lines known to cause bone disruption in animal models of bone metastasis appear to secrete glutamate into their extracellular environment in vitro. Although these cells also express specific glutamate receptors, the implications of this potentially disruptive chemical signal are discussed in relation to normal glutamate-dependent communication processes in bone and a possible mechanistic connection is made between tumour cell glutamate release and the development of pathological changes in bone turnover.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19526315     DOI: 10.1007/s10585-009-9277-4

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  51 in total

1.  Regulation of spontaneous glutamate release activity in osteoblastic cells and its role in differentiation and survival: evidence for intrinsic glutamatergic signaling in bone.

Authors:  P G Genever; T M Skerry
Journal:  FASEB J       Date:  2001-07       Impact factor: 5.191

2.  Demonstration of expression of mRNA for particular AMPA and kainate receptor subunits in immature and mature cultured rat calvarial osteoblasts.

Authors:  Eiichi Hinoi; Sayumi Fujimori; Akihiro Takemori; Hiroaki Kurabayashi; Yoichi Nakamura; Yukio Yoneda
Journal:  Brain Res       Date:  2002-07-05       Impact factor: 3.252

3.  Functional osteoblastic ionotropic glutamate receptors are a prerequisite for bone formation.

Authors:  A F Taylor
Journal:  J Musculoskelet Neuronal Interact       Date:  2002-09       Impact factor: 2.041

4.  Regulation of the mGluR5, EAAT1 and GS expression by glucocorticoids in MG-63 osteoblast-like osteosarcoma cells.

Authors:  N Kalariti; P Lembessis; E Papageorgiou; N Pissimissis; M Koutsilieris
Journal:  J Musculoskelet Neuronal Interact       Date:  2007 Apr-Jun       Impact factor: 2.041

Review 5.  The role of glutamate in the regulation of bone mass and architecture.

Authors:  T M Skerry
Journal:  J Musculoskelet Neuronal Interact       Date:  2008 Apr-Jun       Impact factor: 2.041

6.  N-methyl-D-aspartate receptor in human prostate cancer.

Authors:  M Abdul; N Hoosein
Journal:  J Membr Biol       Date:  2005-06       Impact factor: 1.843

7.  Doxycycline decreases tumor burden in a bone metastasis model of human breast cancer.

Authors:  Wilhelmina C M Duivenvoorden; Snezana Vukmirović Popović; Sárka Lhoták; Eric Seidlitz; Holger W Hirte; Richard G Tozer; Gurmit Singh
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

8.  The NMDA type glutamate receptors expressed by primary rat osteoblasts have the same electrophysiological characteristics as neuronal receptors.

Authors:  Y Gu; P G Genever; T M Skerry; S J Publicover
Journal:  Calcif Tissue Int       Date:  2002-02-19       Impact factor: 4.333

Review 9.  Skeletal complications of malignancy.

Authors:  R E Coleman
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

10.  Autocrine glutamate signaling promotes glioma cell invasion.

Authors:  Susan A Lyons; W Joon Chung; Amy K Weaver; Toyin Ogunrinu; Harald Sontheimer
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

View more
  38 in total

1.  mGlu Receptors and Cancerous Growth.

Authors:  Jessica Teh; Suzie Chen
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2011-10-25

2.  Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI.

Authors:  Matthew D Budde; Eric Gold; E Kay Jordan; Joseph A Frank
Journal:  Clin Exp Metastasis       Date:  2011-11-01       Impact factor: 5.150

3.  Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells.

Authors:  Jessica L F Teh; Raj Shah; Stephanie La Cava; Sonia C Dolfi; Madhura S Mehta; Sameera Kongara; Sandy Price; Shridar Ganesan; Kenneth R Reuhl; Kim M Hirshfield; Vassiliki Karantza; Suzie Chen
Journal:  Breast Cancer Res Treat       Date:  2015-04-10       Impact factor: 4.872

4.  Expression of metabotropic glutamate receptor 4 in osteosarcoma.

Authors:  Shuo Wang; Xing Wei; Bingyao Chen; Min Zhao; Guangze Song; Zengliang Zhang; Nan Li
Journal:  Mol Clin Oncol       Date:  2015-10-23

5.  High expression of metabotropic glutamate receptor 4: correlation with clinicopathologic characteristics and prognosis of osteosarcoma.

Authors:  Wu Yang; He Maolin; Zhao Jinmin; Wang Zhe
Journal:  J Cancer Res Clin Oncol       Date:  2014-01-08       Impact factor: 4.553

6.  Concurrent Targeting of Glutaminolysis and Metabotropic Glutamate Receptor 1 (GRM1) Reduces Glutamate Bioavailability in GRM1+ Melanoma.

Authors:  Raj Shah; Simar J Singh; Fabian V Filipp; Suzie Chen; Kevinn Eddy
Journal:  Cancer Res       Date:  2019-04-15       Impact factor: 12.701

7.  Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol.

Authors:  Elin Thysell; Izabella Surowiec; Emma Hörnberg; Sead Crnalic; Anders Widmark; Annika I Johansson; Pär Stattin; Anders Bergh; Thomas Moritz; Henrik Antti; Pernilla Wikström
Journal:  PLoS One       Date:  2010-12-03       Impact factor: 3.240

Review 8.  Brain metastasis: Unique challenges and open opportunities.

Authors:  Frank J Lowery; Dihua Yu
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2016-12-06       Impact factor: 10.680

9.  Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine.

Authors:  Kimberly J Briggs; Peppi Koivunen; Shugeng Cao; Keriann M Backus; Benjamin A Olenchock; Hetalben Patel; Qing Zhang; Sabina Signoretti; Gary J Gerfen; Andrea L Richardson; Agnieszka K Witkiewicz; Benjamin F Cravatt; Jon Clardy; William G Kaelin
Journal:  Cell       Date:  2016-06-30       Impact factor: 41.582

10.  Glutamate signaling in healthy and diseased bone.

Authors:  Robert W Cowan; Eric P Seidlitz; Gurmit Singh
Journal:  Front Endocrinol (Lausanne)       Date:  2012-07-19       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.